Insulet Downgraded Despite Expectations For Strong Performance

After a strong run that sent shares of Insulet Corporation (NASDAQ: PODD) up 50 percent over the last year, BTIG analyst Sean Lavin finally sees shares as fairly valued. This pushed him to downgrade Insulet to a Neutral rating.

“We do not feel a reasonable revenue multiple would provide us with a price target with another 15% of upside from here and thus our rating must move to Neutral," Lavin wrote in a note. "This said, management seemed very confident at ADA and as we mention in our preview today, a strong Q2 would not surprise us."

All About The Valuation

Lavin is still very confident in Insulet’s management team as they continue to beat his expectations.

“Our downgrade is entirely based on valuation, with PODD currently trading at ~6.5x EV/Sales on a next twelve month basis, just over 1 standard deviation over its historical average of 5.4x,” he noted.

Shares of Insulet were down 1.46 percent at $49.97 during Monday’s trading session.

To read the latest and exclusive financial news, check out the Benzinga Pro news wire.

Latest Ratings for PODD

Jul 2017	BTIG Research	Downgrades	Buy	Neutral
Jul 2017	Morgan Stanley	Maintains		Equal-Weight
May 2017	BTIG Research	Upgrades	Neutral	Buy

View More Analyst Ratings for PODD
View the Latest Analyst Ratings

See more from Benzinga

• Tableau Software Returns To Bank Of America's Top Picks List

• UBS Revisits The Amazon Ecosystem, Raises Price Target On Stock To ,200

• OCTANe: Helping Drive The Future Of Technological Innovation

© 2017 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.